|
|
|
|
Our results may indicate that antiplatelet drugs did not significantly change the odds of death but reduce the outcome stroke of any cause in patients undergoing CEA. However, it cannot be excluded that the beneficial effect in reducing stroke is caused by chance. It is possible that antiplatelets may increase the odds of hemorrhage, but there are currently too few data to quantify this effect. |
|